Redefining the future of neurotechnology and biopharmacology since 1948.
Founded in 1948 by the former psychology professor Klara Feldmann Nyx and her mathematician husband Alexander Nyx, Nyxcorp International rose to prominence as a pioneer in electroshock therapy throughout the 1950s.
After several tumultuous years in the 80s, during which our cognitive-cloning trials resulted in failure and the tragic loss of doctor Klara Nyx, the company faced serious financial turmoil. In 1989, Alexander Nyx restored the company’s economic status by securing a government contract to provide U.S. military with Noxiderm®, a groundbreaking drug capable of changing a soldier’s brain chemistry to make them more efficient in the battlefield, so that our brave sons and daughters can serve their country with a clear mind.
Nyxcorp has since become a global powerhouse in biopharmacology and neurotechnology, and now stands as a leading provider of mental health solutions on a global scale. Our state-of-the-art well-being facilities all around the United States and in 19 additional countries have helped millions to overcome mental health challenges via advanced and accessible treatment.
Today, under the visionary leadership of Alexander Nyx himself, our Research & Development Division is proud to announce our latest innovation in neurotechnology: Dream State Monitoring & Behavioral Tracking Initiative®, or DSM-BTI®, is a neural therapy model that allows a patient’s dreamscape to be mapped, monitored and analysed with the help of our proprietary virtual assistant, Nyxcore V7®. Though still in the experimental phase, preliminary results indicate that mass production will be greenlit in the coming months.
Alexander Nyx – Founder & CEO
Dr. Marianne Quan – Chief Scientific Officer
Victor Elm – VP of Logistics
Aurelius – Programmer
Cidergis – UI Artist
Deniz Keles – Narrative Designer
Flo Delvo – Composer/Audio Engineer
Gilly Moon – Sound Designer
Kaptain Kratos – Programmer
Seth Rolfe – Tech Designer
Wizradical – 2D Artist